耐多药结核病污名量表在越南的心理测量学评估
在越南完成至少3个月治疗的耐利福平/耐多药结核病患者中,对45条草稿条目进行心理测量学评估,探索性因子分析得到14条目的四因子量表(内疚、社会排斥、物理隔离、责备),内部一致性和重测信度良好。该量表有助于测量污名并评估减少污名的干预措施。
要点
- 14条目四因子量表涵盖内疚、社会排斥、物理隔离和责备。
- 内部一致性Cronbach's Alpha为0.76,重测信度ICC为0.92。
- 量表可用于评估耐多药结核病患者的污名及干预效果。
核心结论
- 研究开发的耐利福平/耐多药结核病污名量表在越南表现出良好的心理测量学特性。
- 该量表有助于测量耐利福平/耐多药结核病患者的污名,并评估减少污名的干预措施。
研究设计与样本
- 邀请已完成至少3个月治疗的耐利福平/耐多药结核病患者填写包含45条草稿污名条目的调查问卷。
- 数据分析包括探索性因子分析、内部一致性、内容效度、标准效度、结构效度和重测信度。
主要发现
- 共315名耐利福平/耐多药结核病患者完成调查。
- 探索性因子分析得到14条目耐利福平/耐多药结核病污名量表,包含内疚、社会排斥、物理隔离和责备四个分量表。
- 内部一致性和重测信度良好(Cronbach's Alpha = 0.76,ICC = 0.92)。
- 结构效度适当,与相关构念呈中度相关。
临床怎么用
- 该量表可用于测量耐利福平/耐多药结核病患者的污名水平。
- 该量表可用于评估减少耐利福平/耐多药结核病患者污名的干预措施效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Stigma contributes to diagnostic delay, disease concealment, and reduced wellbeing for people with multidrug-resistant tuberculosis (MDR-TB) and their communities. Despite the negative effects of stigma, there are no scales to measure stigma in people with MDR-TB. This study aimed to develop and validate a scale to measure stigma in people affected by MDR-TB in Vietnam. STUDY DESIGN AND SETTING: People with rifampicin-resistant (RR)-MDR-TB who had completed at least 3 months of treatment were invited to complete a survey containing 45 draft stigma items. Data analysis included exploratory factor analysis, internal consistency, content, criterion and construct validity, and test-retest reliability. RESULTS: A total of 315 people with RR/MDR-TB completed the survey. Exploratory factor analysis revealed a 14 item RR/MDR-TB stigma scale with four subscales, including guilt, social exclusion, physical isolation, and blame. Internal consistency and test-retest reliability were good (Cronbach's Alpha = 0.76, ICC = 0.92). Construct validity was adequate with moderate correlations with related constructs. CONCLUSION: Our RR/MDR-TB Scale demonstrated good psychometric properties in Vietnam. This scale will assist in the measurement of stigma in people with RR/MDR-TB. It will also aid in the evaluation of stigma reduction interventions in people with RR/MDR-TB.
引用
- Redwood L, Mitchell EMH, Nguyen TA, et al. Psychometric evaluation of a new drug-resistant tuberculosis stigma scale. J Clin Epidemiol. 2021. PMID: 33476766. doi:10.1016/j.jclinepi.2021.01.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。